Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease
Michael Spencer Chapman(Wellcome Sanger Institute), David G. Kent(University of York), Alyssa Cull(Queen's University), Myriam Armant(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), James M. Fox(University of York), Marioara F. Ciuculescu(Boston Children's Hospital), Peter J. Campbell(Wellcome Sanger Institute), Emily Mitchell(Wellcome/MRC Cambridge Stem Cell Institute), Julie Makani(Muhimbili University of Health and Allied Sciences), David A. Williams(Boston Children's Hospital), Margarete A. Fabre(University of Cambridge), Nicholas Williams(Wellcome Sanger Institute), Danilo Pellin(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Laura P. O’Neill(Wellcome Sanger Institute), Kirsty Roberts(Wellcome Sanger Institute), Jyoti Nangalia(Wellcome Sanger Institute), Hyunchul Jung(Wellcome Sanger Institute), Joanne Quinton(University of York), Erica B. Esrick(Broad Institute)
Cited by 55
Related Papers
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
|Nucleic Acids Research|2014|2.4k